Showing results (241-250 of 339) with videos related to

Sort By:
Pageof 34
The Lancet Regional Health. Western Pacific|December 18, 2023
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyNobuaki Nakano, Hideki Nakasone, Shigeo Fuji, et al.
Frontiers in Immunology|February 13, 2025
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experienceYusuke Uchibori, Shuhei Kurosawa, Yuho Najima, et al.
Blood Advances|September 29, 2020
Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantationKota Yoshifuji, Kyoko Inamoto, Yuko Kiridoshi, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|December 16, 2014
The molecular basis of myeloid malignanciesToshio Kitamura, Daichi Inoue, Naoko Okochi-Watanabe, et al.
Annals of Hematology|June 12, 2020
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantationSatoshi Kaito, Atsushi Wada, Hiroto Adachi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant]Yuka Morita, Yu Yagi, Yusuke Kanemasa, et al.
British Journal of Haematology|April 28, 2026
Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patientsYusuke Toda, Tomoyasu Jo, Yasuyuki Arai, et al.
American Journal of Hematology|May 23, 2025
Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First TransplantationKazuki Yoshimura, Hideki Nakasone, Masaharu Tamaki, et al.
BMC Infectious Diseases|September 24, 2017
Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantationKaito Harada, Noritaka Sekiya, Tatsuya Konishi, et al.
International Journal of Hematology|August 27, 2025
Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial dataSatoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, et al.
Pageof 34